Richard L. Somberg

Promega (United States)

Papers

1

Total Citations

49

H-Index

1

About

Richard L. Somberg is a biochemist and assay development specialist whose work has advanced high-throughput screening technologies for protein kinases. His key research areas include kinase biochemistry, fluorescence-based assay design, and drug discovery methodologies. Somberg’s most notable contribution is the development of a homogeneous, nonradioactive fluorogenic protein kinase assay, published in 2003, which has garnered 49 citations. This method eliminated the need for radioactive isotopes, offering a safer, faster, and more scalable approach to measuring kinase activity—a critical step in cancer and inflammatory disease research. By enabling high-throughput screening in microtiter plates, Somberg’s work directly supported the identification of kinase inhibitors, a cornerstone of modern targeted therapies. His assay remains a foundational tool for laboratories seeking to streamline drug discovery pipelines. Though his citation count reflects focused impact rather than broad recognition, Somberg’s innovation exemplifies how methodological advances can transform preclinical research, making him a valuable contributor to the field of chemical biology and pharmaceutical development.

Research Focus

Key Achievements

1
H-Index
1
Papers
49
Total Citations
49
Avg Citations/Paper
🏆 Most Cited Paper
A homogeneous, nonradioactive high-throughput fluorogenic protein kinase assay
49 citations · 2003
📈 Most Prolific Year: 2003 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Promega (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago